Lincoln Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

311.00 -7.55 ▼-2.4%

27 January 2023, 04:01:00 PM
Volume: 6,799

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lincolnpharma.com
Market Cap 623.33 Cr.
Enterprise Value(EV) 613.63 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 33.63 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 9.25 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 233.98 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.33 Calculated using Price: 311.00
Dividend Yield 0.48 Period Ending 2022-03
No. of Shares Subscribed 2.00 Cr. 20,029,728 Shares
FaceValue 10
Company Profile
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.37%
1 Week
-7.84%
1 Month
-9.32%
3 Month
+5.84%
6 Month
+4.07%
1 Year
-11.69%
2 Year
+38.59%
5 Year
+25.43%
10 Year
+621.58%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.83 14.32 19.49 17.29 16.63 19.75 17.67 18.32 17.35
Return on Capital Employed (%) 11.48 15.91 21.18 18.51 19.05 22.50 22.30 24.90 24.29
Return on Assets (%) 4.10 5.77 8.87 9.40 10.09 12.80 12.33 13.48 13.31

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 99 111 141 192 224 269 313 366 433 469
Non Curr. Liab. 26 33 34 32 25 28 43 26 11 11
Curr. Liab. 131 114 100 99 113 100 80 95 111 124
Minority Int. 4 3 0 0 0 0 0
Equity & Liab. 260 262 275 324 363 399 437 487 555 603
Non Curr. Assets 111 81 128 134 136 159 174 160 182 189
Curr. Assets 149 181 147 190 227 239 263 328 373 414
Misc. Exp. not W/O
Total Assets 260 262 275 324 363 399 437 487 555 603

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 210 266 400 360 361 366 386 424 472 487
Other Income 2 7 7 3 5 6 11 6 10 17
Total Income 213 273 408 363 366 372 398 430 482 503
Total Expenditure -190 -240 -360 -314 -308 -299 -321 -337 -377 -400
PBIDT 23 33 48 50 58 73 77 93 105 103
Interest -7 -8 -10 -7 -5 -4 -2 -2 -1 -1
Depreciation -4 -5 -5 -6 -6 -7 -7 -8 -8 -9
Taxation -2 -5 -9 -9 -12 -13 -16 -21 -27 -26
Exceptional Items
PAT 10 15 24 28 35 49 51 62 69 67
Minority Interest 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 11 15 24 28 35 49 51 62 69 67
Adjusted EPS 7 9 15 14 17 24 26 31 35 34

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -16 5 25 45 25 27 53 75 69 76
Cash Fr. Inv. -16 1 7 -42 -25 -12 -18 -31 -64 -78
Cash Fr. Finan. 29 -11 -32 -3 0 -11 -36 -38 -6 -3
Net Change -3 -4 -1 0 0 3 -1 7 -1 -5
Cash & Cash Eqvt 9 5 4 3 3 7 5 12 11 7

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 33.41 37.26 37.78 40.28 42.08 42.05 44.08 44.08 46.34
Public 66.59 62.74 62.22 59.72 57.92 57.95 55.92 55.92 53.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to provision of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 we hereby submit the confirmation certificate received from Link Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter Ended December 31 2022.
Wed, 28 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs
Thu, 22 Dec 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Lincoln Pharmaceuticals Ltd.

What is Lincoln Pharma share price?
Can I buy Lincoln Pharma shares now?
What is the Dividend Yield of Lincoln Pharma?
What is the Market Cap of Lincoln Pharma?
What are the key metrics to analyse Lincoln Pharma?
What is the 52 Week High and Low of Lincoln Pharma?
What is the trend of Lincoln Pharma share price?